ASKREN STANLEY A
Known title: DirectorCIK: 0001195347
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Allison Transmission Completes Partial Note Redemption. Allison Transmission finished a partial redemption of its 4.750% senior notes due 2027, reducing debt and improving its balance sheet. A recent analysis highlighted the company’s solid fundamentals and steady performance, noting its 52‑week range and dividend yield. The redemption aligns with the company’s focus on financial strength, while analysts maintain a target range of $115‑$185. The stock remains near its 200‑day moving average support level.
Transaction History
| SLVM | ▲ Buy | Grant | 2,655 | $150K | 5/15/2025 | View on chart |
| SLVM | ▲ Buy | Grant | 2,491 | $175K | 5/16/2024 | View on chart |
| SLVM | ▲ Buy | Grant | 4,149 | $0 | 5/16/2023 | View on chart |
| ALSN | ▲ Buy | Option Exercise | 8,536 | $0 | 5/3/2023 | View on chart |
| ALSN | ▲ Buy | Option Exercise | 3,823 | $0 | 5/3/2023 | View on chart |
| SLVM | ▲ Buy | Grant | 2,623 | $0 | 5/16/2022 | View on chart |
| ALSN | ▲ Buy | Option Exercise | 2,985 | $0 | 5/4/2022 | View on chart |
| SLVM | ▲ Buy | Grant | 2,809 | $0 | 10/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Sylvamo Price Targets Lowered by BofA and Truist
Bank of America and Truist Securities recently lowered their price targets for Sylvamo, citing updated outlooks. While BofA maintains a Neutral rating with a $42 target, Truist keeps a Buy rating but reduced its target to $40. These adjustments place the new targets below the current average analyst estimate of $50.40, reflecting a more cautious view on the company's near-term valuation.
Sylvamo Price Targets Lowered by BofA and Truist. Bank of America and Truist Securities recently lowered their price targets for Sylvamo, citing updated outlooks. While BofA maintains a Neutral rating with a $42 target, Truist keeps a Buy rating but reduced its target to $40. These adjustments place the new targets below the current average analyst estimate of $50.40, reflecting a more cautious view on the company's near-term valuation.